NAD+ IV is a $300–800 longevity industry staple, but the science is more complicated than the marketing. Here's what NAD+ IV actually does, the best clinics and at-home kits in 2026, and whether oral precursors might be the better deal.
Walk into any longevity clinic in Los Angeles, Miami, or New York in 2026 and you'll be offered an NAD+ infusion. The standard protocol — 500 to 1000 mg of intravenous nicotinamide adenine dinucleotide over 2–4 hours — runs $300 to $800 per session. Multi-session packages are common. The marketing suggests dramatic energy improvements, cognitive enhancement, and reversal of biological aging.
The science is more nuanced. NAD+ levels do decline with age, and restoring them does have measurable effects on cellular metabolism. But intravenous infusion is not obviously superior to oral precursors at a fraction of the cost. This guide explains what NAD+ IV actually does, ranks the clinics and at-home options in 2026, and helps you decide whether to spend the money.
Nicotinamide adenine dinucleotide is a coenzyme involved in over 500 enzymatic reactions, most importantly in mitochondrial energy production, DNA repair (via PARP enzymes), and sirtuin activation. Tissue NAD+ levels decline with age — roughly 50% by age 60 in skeletal muscle and brain — driven primarily by increased consumption (chronic inflammation activates NAD+-consuming enzymes like CD38) rather than decreased synthesis.
Restoring NAD+ improves mitochondrial function in mouse models, partially reverses age-related decline in multiple tissues, and (in some animal studies) extends lifespan. The translation question for humans is whether NAD+ restoration produces clinically meaningful benefits — and what's the most efficient way to achieve it.
When you receive 500–1000 mg of NAD+ intravenously, plasma NAD+ rises dramatically during the infusion, then falls back toward baseline within hours. Critically, intracellular NAD+ levels in muscle, liver, and brain do not rise proportionally — most NAD+ is metabolized to nicotinamide before entering cells. Cells preferentially synthesize NAD+ from precursors (NMN, NR, niacinamide) rather than from intact NAD+.